Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Vickers
    Vickers
  2. Eastham
    Eastham
  3. Lilja
    Lilja
  4. Scardino
    Scardino
  5. Vertosick
    Vertosick
  6. Touijer
    Touijer
  7. Assel
    Assel
  8. Laudone
    Laudone
  9. Ehdaie
    Ehdaie
  10. Carlsson
    Carlsson

Groups

  1. Epidemiology and Biostatistics (223)
  2. Health Outcomes Research Group (223)
  3. Population Sciences Research Program (223)
  4. Surgery (124)
  5. Urology (124)
  6. Molecular Pharmacology and Chemistry Program Faculty (47)
  7. Sloan Kettering Institute Faculty (47)
  8. Department of Pathology and Laboratory Medicine (22)
  9. Josie Robertson Surgery Center (21)
  10. Survivorship Research (14)
Search Within
  1. "Andrew Vickers"
Formats
  1. Journal Article (176)
  2. Correspondence (18)
  3. Editorial (16)
  4. Meeting Abstract (8)
  5. Guidelines (4)
  6. Research Letter (1)
Groups
  1. Epidemiology and Biostatistics (223)
  2. Health Outcomes Research Group (223)
  3. Population Sciences Research Program (223)
  4. Surgery (124)
  5. Urology (124)
  6. Molecular Pharmacology and Chemistry Program Faculty (47)

More Groups

People
  1. Andrew Vickers (223)
  2. Daniel Sjoberg (50)
  3. Peter Scardino (47)
  4. James Eastham (45)
  5. Hans Lilja (34)
  6. Melissa Assel (31)

More People

Years
  1. 2025 (6)
  2. 2024 (19)
  3. 2023 (12)
  4. 2022 (18)
  5. 2021 (7)
  6. 2020 (14)

More Years

Publications
  1. European Urology (110)
  2. Journal of Urology (72)
  3. Urology (32)
  4. Lancet Oncology (4)
  5. Ophthalmology (2)
  6. Controlled Clinical Trials (1)

More Publications

Results (223)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The quantification of GSP4 volume is superior to ISUP GG classification and %GSP4 for predicting adverse outcomes in radical prostatectomy patients
    Meeting Abstract

    Scuderi, S. L. A.; Tin, A.; Stabile, A.; Mazzone, E.; Quarta, L.; Zaurito, P.; Ciabattini, M.; Cosenza, A.; Brancaccio, M.; Leni, R.; more...
    European Urology (2024)

    Fulltext@MSK | Save
  • Re: Michael Baboudjian, Romain Diamand, Alessandro Uleri, et al. Does overgrading on targeted biopsy of magnetic resonance imaging–visible lesions in prostate cancer lead to overtreatment? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.02.003
    Correspondence

    Vickers, A. J.
    European Urology (2024)

    Fulltext@MSK | Save
  • Performance of 4Kscore as a reflex test to prostate-specific antigen in the GÖTEBORG-2 prostate cancer screening trial
    Journal Article

    Josefsson, A.; Månsson, M.; Kohestani, K.; Spyratou, V.; Wallström, J.; Hellström, M.; Lilja, H.; Vickers, A.; Carlsson, S. V.; Godtman, R.; more...
    European Urology (2024)

    Fulltext@MSK | Save
  • Reply to Giancarlo Marra, Marco Oderda, Paolo Gontero, and Lorenzo Richiardi's Letter to the editor re: Jim C. Hu, Melissa Assel, Mohamad E. Allaf, et al. Transrectal magnetic resonance imaging–targeted and systematic prostate biopsy to prevent infectious complications: The PREVENT Randomized trial. Eur Urol. 2024;86:61–68
    Correspondence

    Hu, J. C.; Allaf, M. E.; Vickers, A. J.; Schaeffer, E. M.
    European Urology (2024)

    Fulltext@MSK | Save
  • Randomized trial of transverse vs vertical extraction site incision after robotic radical prostatectomy
    Journal Article

    Gaffney, C. D.; Vertosick, E. A.; Laudone, V.; Goh, A. C.; Carlsson, S. V.; Pietzak, E.; Donahue, T.; Smith, R.; Touijer, K.; Vickers, A. J.; more...
    Journal of Urology (2024)

    Fulltext@MSK | Save
  • Estimating the effect of radical prostatectomy: Combining data from the SPCG4 and pivot randomized trials with contemporary cohorts
    Journal Article

    Vickers, A.; Vertosick, E.; Langsetmo, L.; Dahm, P.; Steineck, G.; Wilt, T. J.
    Journal of Urology (2024)

    Fulltext@MSK | Save
  • Reply to Peter Ka-Fung Chiu, Xiaobo Wu, Giorgio Gandaglia, European Association of Urology Young Academic Urologists Prostate Cancer Working Party. Beyond Statistical Significance: Unveiling the Advantages of Transperineal Versus Transrectal Prostate Biopsies. Eur Urol. In press
    Correspondence

    Hu, J. C.; Vickers, A. J.; Schaeffer, E. M.
    European Urology (2024)

    Fulltext@MSK | Save
  • Baseline serum prostate-specific antigen value predicts the risk of subsequent prostate cancer death—Results from the Norwegian Prostate Cancer Consortium
    Journal Article

    Bjerner, J.; Bratt, O.; Aas, K.; Albertsen, P. C.; Fosså, S. D.; Kvåle, R.; Lilja, H.; Müller, C.; Müller, S.; Stensvold, A.; more...
    European Urology (2024)

    Fulltext@MSK | Save
  • Reply to Ilias Giannakodimos’ letter to the editor re: Jim C. Hu, Melissa Assel, Mohamad E. Allaf, et al. Transperineal versus transrectal magnetic resonance imaging-targeted and systematic prostate biopsy to prevent infectious complications: The PREVENT randomized trial. Eur Urol. 2024;86:61–68
    Correspondence

    Hu, J. C.; Schaeffer, E. M.; Vickers, A. J.
    European Urology (2024)

    Fulltext@MSK | Save
  • Reply to Geoffrey H. Rosen, Nicholas H. Chakiryan, and Katie S. Murray's Letter to the Editor re: Jim C. Hu, Melissa Assel, Mohamad E. Allaf, et al. Transperineal versus transrectal magnetic resonance imaging–targeted and systematic prostate biopsy to prevent infectious complications: The PREVENT randomized trial. Eur Urol. 2024;86:61–68
    Correspondence

    Hu, J. C.; Vickers, A. J.; Schaeffer, E. M.
    European Urology (2024)

    Fulltext@MSK | Save